Caroline Rosenstand - Coloplast Executive Commercial
| CBHD Stock | EUR 65.08 0.28 0.43% |
Executive
Caroline Rosenstand is Executive Commercial of Coloplast AS
| Age | 47 |
| Address | Holtedam 1-3, Humlebæk, Denmark, 3050 |
| Phone | 45 49 11 11 11 |
| Web | https://www.coloplast.com |
Coloplast Management Efficiency
The company has return on total asset (ROA) of 0.0985 % which means that it generated a profit of $0.0985 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2726 %, meaning that it generated $0.2726 on every $100 dollars invested by stockholders. Coloplast's management efficiency ratios could be used to measure how well Coloplast manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Coloplast's Non Current Assets Total are most likely to increase significantly in the upcoming years.Similar Executives
| Found 3 records | EXECUTIVE Age | ||
| Sujal Shah | Cerence | N/A | |
| Christian Mentz | Cerence | 45 | |
| Nils Schanz | Cerence | 43 | |
Management Performance
| Return On Equity | 0.27 | ||||
| Return On Asset | 0.0985 |
Coloplast AS Leadership Team
Elected by the shareholders, the Coloplast's board of directors comprises two types of representatives: Coloplast inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Coloplast. The board's role is to monitor Coloplast's management team and ensure that shareholders' interests are well served. Coloplast's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Coloplast's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ellen Bjurgert, VP Relations | ||
| Allan Rasmussen, Executive Vice President Global Operations; Member of the Executive Management | ||
| Alain Morvan, Senior Vice President Sales Europe | ||
| Nicolai Andersen, Senior Vice President Wound Care | ||
| Thomas Barfod, Director, Employee Representative | ||
| Kristian Villumsen, Executive Vice President Chronic Care; Member of the Executive Management | ||
| Dennis Kaysen, Director Communications | ||
| Anders LonningSkovgaard, CFO, Executive Vice President Member of the Executive Management | ||
| Aleksandra Dimovska, Vice Relations | ||
| Caroline Rosenstand, Executive Commercial | ||
| Paul Marcun, Senior Vice President Emerging Markets | ||
| Dorthe Ronnau, Executive Culture | ||
| Lars Rasmussen, Interim President |
Coloplast Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Coloplast a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.27 | ||||
| Return On Asset | 0.0985 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 17.54 B | ||||
| Shares Outstanding | 207.37 M | ||||
| Shares Owned By Insiders | 29.79 % | ||||
| Shares Owned By Institutions | 28.94 % | ||||
| Price To Earning | 38.18 X | ||||
| Price To Book | 7.81 X |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Coloplast Stock
Coloplast financial ratios help investors to determine whether Coloplast Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Coloplast with respect to the benefits of owning Coloplast security.